WILMINGTON, Del.--(BUSINESS WIRE)--Jan. 7, 2005--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 23rd Annual JPMorgan Healthcare Conference on Thursday, January 13, 2005 at 9:30 a.m. (PT). Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and discuss its most advanced drug discovery and development programs.
